Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC) Meeting Abstract
| Authors: | Rischin, D.; Migden, M. R.; Chang, A.; Chung, C. H.; Dunn, L.; Guminski, A.; Hauschild, A.; Hernandez-Aya, L.; Hughes, B. G. M.; Lewis, K. D.; Lim, A. M. L.; Modi, B.; Schadendorf, D.; Schmults, C.; Booth, J.; Li, S.; Mohan, K. K.; Stankevich, E.; Lowy, I.; Fury, M. G. |
| Abstract Title: | Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 494s |
| Language: | English |
| ACCESSION: | WOS:000442916003296 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9519 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9519 -- Source: Wos |
